Poxel's Series A Round

Poxel raised a round of funding on July 23, 2010.

Poxel is a biopharmaceutical company developing first-in-class drugs, with a primary focus on Type 2 diabetes. The company develops drug candidates to clinical proof-of-concept before seeking pharmace…

Articles about Poxel's Series A Round: